Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM.

Nordestgaard BG, Langlois MR, Langsted A, Chapman MJ, Aakre KM, Baum H, Borén J, Bruckert E, Catapano A, Cobbaert C, Collinson P, Descamps OS, Duff CJ, von Eckardstein A, Hammerer-Lercher A, Kamstrup PR, Kolovou G, Kronenberg F, Mora S, Pulkki K, Remaley AT, Rifai N, Ros E, Stankovic S, Stavljenic-Rukavina A, Sypniewska G, Watts GF, Wiklund O, Laitinen P; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative.

Atherosclerosis. 2020 Jan 9. pii: S0021-9150(19)31623-5. doi: 10.1016/j.atherosclerosis.2019.12.005. [Epub ahead of print] Review.

PMID:
31928713
2.

Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau).

Prause LW, Manka L, Millan C, Lang E, Wyler SF, Grobholz R, Hammerer-Lercher A, Sulser T, Recker F, Kwiatkowski M, Eberli D.

World J Urol. 2019 Dec 21. doi: 10.1007/s00345-019-03054-5. [Epub ahead of print]

PMID:
31865534
3.

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.

Langlois MR, Nordestgaard BG, Langsted A, Chapman MJ, Aakre KM, Baum H, Borén J, Bruckert E, Catapano A, Cobbaert C, Collinson P, Descamps OS, Duff CJ, von Eckardstein A, Hammerer-Lercher A, Kamstrup PR, Kolovou G, Kronenberg F, Mora S, Pulkki K, Remaley AT, Rifai N, Ros E, Stankovic S, Stavljenic-Rukavina A, Sypniewska G, Watts GF, Wiklund O, Laitinen P; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative.

Clin Chem Lab Med. 2019 Dec 19. pii: /j/cclm.ahead-of-print/cclm-2019-1253/cclm-2019-1253.xml. doi: 10.1515/cclm-2019-1253. [Epub ahead of print]

PMID:
31855562
4.

Emerging biomarkers for cardiac arrhythmias.

Hammerer-Lercher A, Namdar M, Vuilleumier N.

Clin Biochem. 2020 Jan;75:1-6. doi: 10.1016/j.clinbiochem.2019.11.012. Epub 2019 Nov 28. Review.

PMID:
31786205
5.

Prevalence of Pulmonary Embolism in Patients With Syncope.

Badertscher P, du Fay de Lavallaz J, Hammerer-Lercher A, Nestelberger T, Zimmermann T, Geiger M, Imahorn O, Miró Ò, Salgado E, Christ M, Cullen L, Than M, Martin-Sanchez FJ, Di Somma S, Peacock WF, Keller DI, Costabel JP, Walter J, Boeddinghaus J, Twerenbold R, Méndez A, Gospodinov B, Puelacher C, Wussler D, Koechlin L, Kawecki D, Geigy N, Strebel I, Lohrmann J, Kühne M, Reichlin T, Mueller C; BASEL IX Investigators.

J Am Coll Cardiol. 2019 Aug 13;74(6):744-754. doi: 10.1016/j.jacc.2019.06.020.

PMID:
31395124
6.

Validation of a Prediction Rule for Legionella Pneumonia in Emergency Department Patients.

Bolliger R, Neeser O, Merker M, Vukajlovic T, Felder L, Fiumefreddo R, Haubitz S, Koch D, Hammerer-Lercher A, Ottiger C, Fux CA, Mueller B, Schuetz P.

Open Forum Infect Dis. 2019 Jun 4;6(7):ofz268. doi: 10.1093/ofid/ofz268. eCollection 2019 Jul.

7.

Variable and inaccurate serum IgG4 levels resulting from lack of standardization in IgG subclass assay calibration.

Bernasconi L, Mundwiler E, Regenass S, Aubert V, Hammerer-Lercher A, Heijnen I.

Clin Chem Lab Med. 2019 Oct 25;57(11):1777-1783. doi: 10.1515/cclm-2019-0261.

PMID:
31188751
8.

A high C-reactive protein/procalcitonin ratio predicts Mycoplasma pneumoniae infection.

Neeser OL, Vukajlovic T, Felder L, Haubitz S, Hammerer-Lercher A, Ottiger C, Mueller B, Schuetz P, Fux CA.

Clin Chem Lab Med. 2019 Sep 25;57(10):1638-1646. doi: 10.1515/cclm-2019-0194.

PMID:
31128571
9.

Daytime variation of perioperative myocardial injury in non-cardiac surgery and effect on outcome.

du Fay de Lavallaz J, Puelacher C, Lurati Buse G, Bolliger D, Germanier D, Hidvegi R, Walter JE, Twerenbold R, Strebel I, Badertscher P, Sazgary L, Lampart A, Espinola J, Kindler C, Hammerer-Lercher A, Thambipillai S, Guerke L, Rentsch K, Buser A, Gualandro D, Jakob M, Mueller C; BASEL-PMI Investigators.

Heart. 2019 Jun;105(11):826-833. doi: 10.1136/heartjnl-2018-313876. Epub 2018 Dec 12.

PMID:
30541757
10.

Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery.

Gualandro DM, Puelacher C, LuratiBuse G, Lampart A, Strunz C, Cardozo FA, Yu PC, Jaffe AS, Barac S, Bock L, Badertscher P, du Fay de Lavallaz J, Marbot S, Sazgary L, Bolliger D, Rentsch K, Twerenbold R, Hammerer-Lercher A, Melo ES, Calderaro D, Duarte AJ, de Luccia N, Caramelli B, Mueller C; TropoVasc and BASEL-PMI Investigators.

Am Heart J. 2018 Sep;203:67-73. doi: 10.1016/j.ahj.2018.06.012. Epub 2018 Jul 5.

PMID:
30041065
11.

Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure.

Halfinger B, Hammerer-Lercher A, Amplatz B, Sarg B, Kremser L, Lindner HH.

Clin Chem. 2017 Jan;63(1):359-368. doi: 10.1373/clinchem.2016.265397. Epub 2016 Nov 8.

12.

How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).

Collinson P, Hammerer-Lercher A, Suvisaari J, Apple FS, Christenson RH, Pulkki K, van Dieijen-Visser MP, Duff CJ, Baum H, Stavljenic-Rukavina A, Aakre KM, Langlois MR, Stankovic S, Laitinen P; Working Group for Cardiac Markers, European Federation of Clinical Chemistry and Laboratory Medicine.

Clin Chem. 2016 Sep;62(9):1264-71. doi: 10.1373/clinchem.2016.259515. Epub 2016 Jul 26.

13.

Influence of the delivery modus on subpopulations and replication of lymphocytes in mothers and newborns.

Almanzar G, Schönlaub J, Hammerer-Lercher A, Koppelstaetter C, Bernhard D, Prelog M.

Early Hum Dev. 2015 Dec;91(12):663-70. doi: 10.1016/j.earlhumdev.2015.09.010. Epub 2015 Oct 26.

PMID:
26513626
14.

Biomarkers of hemodynamic stress and aortic stiffness after STEMI: a cross-sectional analysis.

Reinstadler SJ, Feistritzer HJ, Klug G, Mayr A, Huybrechts L, Hammerer-Lercher A, Mair J, Franz WM, Metzler B.

Dis Markers. 2015;2015:717032. doi: 10.1155/2015/717032. Epub 2015 Apr 16.

15.

Serum concentrations of L-arginine and L-homoarginine in male patients with intermittent claudication: a cross-sectional and prospective investigation in the CAVASIC Study.

Vogl L, Pohlhammer J, Meinitzer A, Rantner B, Stadler M, Peric S, Hammerer-Lercher A, Klein-Weigel P, Fraedrich G, Kronenberg F, Kollerits B.

Atherosclerosis. 2015 Apr;239(2):607-14. doi: 10.1016/j.atherosclerosis.2015.02.019. Epub 2015 Feb 16.

PMID:
25746168
16.

Left ventricular ejection fraction is associated with prevalent and incident cardiovascular disease in patients with intermittent claudication - results from the CAVASIC Study.

Rantner B, Pohlhammer J, Stadler M, Peric S, Hammerer-Lercher A, Klein-Weigel P, Fraedrich G, Kronenberg F, Kollerits B.

Atherosclerosis. 2015 Apr;239(2):428-35. doi: 10.1016/j.atherosclerosis.2014.12.060. Epub 2015 Jan 17.

PMID:
25682043
17.

Outcome prediction and temperature dependency of MR-proANP and Copeptin in comatose resuscitated patients.

Broessner G, Hasslacher J, Beer R, Lackner P, Lehner GF, Harler U, Schiefecker A, Helbok R, Pfausler B, Hammerer-Lercher A, Joannidis M.

Resuscitation. 2015 Apr;89:75-80. doi: 10.1016/j.resuscitation.2015.01.013. Epub 2015 Jan 22.

PMID:
25619444
18.

High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality--the CAVASIC Study.

Pohlhammer J, Kronenberg F, Rantner B, Stadler M, Peric S, Hammerer-Lercher A, Klein-Weigel P, Fraedrich G, Kollerits B.

Atherosclerosis. 2014 Dec;237(2):711-7. doi: 10.1016/j.atherosclerosis.2014.10.097. Epub 2014 Oct 29.

PMID:
25463110
19.

Intense illumination in the morning hours improved mood and alertness but not mental performance.

Leichtfried V, Mair-Raggautz M, Schaeffer V, Hammerer-Lercher A, Mair G, Bartenbach C, Canazei M, Schobersberger W.

Appl Ergon. 2015 Jan;46 Pt A:54-9. doi: 10.1016/j.apergo.2014.07.001. Epub 2014 Aug 5.

PMID:
25106786
20.

Effects of 24 h working on-call on psychoneuroendocrine and oculomotor function: a randomized cross-over trial.

Ernst F, Rauchenzauner M, Zoller H, Griesmacher A, Hammerer-Lercher A, Carpenter R, Schuessler G, Joannidis M.

Psychoneuroendocrinology. 2014 Sep;47:221-31. doi: 10.1016/j.psyneuen.2014.05.019. Epub 2014 Jun 2.

PMID:
24955858
21.

Association of aortic stiffness with biomarkers of myocardial wall stress after myocardial infarction.

Klug G, Feistritzer HJ, Reinstadler SJ, Krauter L, Mayr A, Mair J, Hammerer-Lercher A, Kremser C, Schocke M, Metzler B.

Int J Cardiol. 2014 May 1;173(2):253-8. doi: 10.1016/j.ijcard.2014.02.038. Epub 2014 Mar 7.

PMID:
24650659
22.

The association of relative telomere length with symptomatic peripheral arterial disease: results from the CAVASIC study.

Raschenberger J, Kollerits B, Hammerer-Lercher A, Rantner B, Stadler M, Haun M, Klein-Weigel P, Fraedrich G, Kronenberg F.

Atherosclerosis. 2013 Aug;229(2):469-74. doi: 10.1016/j.atherosclerosis.2013.05.027. Epub 2013 Jun 10.

PMID:
23880207
23.

High-sensitivity cardiac troponin T compared with standard troponin T testing on emergency department admission: how much does it add in everyday clinical practice?

Hammerer-Lercher A, Ploner T, Neururer S, Schratzberger P, Griesmacher A, Pachinger O, Mair J.

J Am Heart Assoc. 2013 Jun 4;2(3):e000204. doi: 10.1161/JAHA.113.000204.

24.

Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction.

Reinstadler SJ, Klug G, Feistritzer HJ, Mayr A, Harrasser B, Mair J, Bader K, Streil K, Hammerer-Lercher A, Esterhammer R, Metzler B.

Heart. 2013 Oct;99(20):1525-9. doi: 10.1136/heartjnl-2013-303975. Epub 2013 May 22.

PMID:
23697651
25.

Do laboratories follow heart failure recommendations and guidelines and did we improve? The CARdiac MArker Guideline Uptake in Europe (CARMAGUE).

Hammerer-Lercher A, Collinson P, van Dieijen-Visser MP, Pulkki K, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Baum H, Laitinen P.

Clin Chem Lab Med. 2013 Jun;51(6):1301-6. doi: 10.1515/cclm-2012-0510.

PMID:
23334056
26.

Comparison and evaluation of cardiac biomarkers in patients with intermittent claudication: results from the CAVASIC study.

Kollerits B, Sturm G, Lamina C, Hammerer-Lercher A, Rantner B, Stadler M, Ziera T, Struck J, Klein-Weigel P, Fraedrich G, Kronenberg F.

Clin Chem. 2013 Apr;59(4):692-702. doi: 10.1373/clinchem.2012.193656. Epub 2013 Jan 11.

27.

The high-sensitivity cardiac troponin T assay is superior to its previous assay generation for prediction of 90-day clinical outcome in ischemic stroke.

Furtner M, Ploner T, Hammerer-Lercher A, Pechlaner R, Mair J.

Clin Chem Lab Med. 2012 Nov;50(11):2027-9.

PMID:
22745020
28.

Comparison of a commercial urinary neopterin radioimmunoassay with high performance liquid chromatography.

Hammerer-Lercher A, Moser C, Leichtfried V, Schobersberger W, Griesmacher A, Fuchs D.

Clin Chem Lab Med. 2012 Jan 14;50(6):1075-8. doi: 10.1515/cclm-2011-0861.

PMID:
22706249
29.

Antimicrobial and anticoagulant activities of N-chlorotaurine, N,N-dichloro-2,2-dimethyltaurine, and N-monochloro-2,2-dimethyltaurine in human blood.

Martini C, Hammerer-Lercher A, Zuck M, Jekle A, Debabov D, Anderson M, Nagl M.

Antimicrob Agents Chemother. 2012 Apr;56(4):1979-84. doi: 10.1128/AAC.05685-11. Epub 2012 Jan 17.

30.

Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study.

Collinson PO, van Dieijen-Visser MP, Pulkki K, Hammerer-Lercher A, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Baum H, Laitinen P.

Clin Chem. 2012 Jan;58(1):305-6. doi: 10.1373/clinchem.2011.171439. Epub 2011 Sep 27. No abstract available.

31.

Unmasking low-abundance peptides from human blood plasma and serum samples by a simple and robust two-step precipitation/immunoaffinity enrichment method.

Halfinger B, Sarg B, Amann A, Hammerer-Lercher A, Lindner HH.

Electrophoresis. 2011 Jun;32(13):1706-14. doi: 10.1002/elps.201100069. Epub 2011 May 24.

PMID:
21607990
32.

Clinical value of a competitive NT-proBNP enzyme immunoassay compared to the Roche NT-proBNP platform.

Hammerer-Lercher A, Griesmacher A, Pölzl G, Brinskelle-Schmal N, Mair J, Frick M, Hawa G.

Clin Chem Lab Med. 2009;47(10):1305-8. doi: 10.1515/CCLM.2009.279. No abstract available.

PMID:
19751139
33.

Pulmonary epithelial lining fluid concentrations after use of systemic amphotericin B lipid formulations.

Weiler S, Falkensammer G, Hammerer-Lercher A, Anliker M, Vogelsinger H, Joannidis M, Dunzendorfer S, Stein M, Bellmann R.

Antimicrob Agents Chemother. 2009 Nov;53(11):4934-7. doi: 10.1128/AAC.00796-09. Epub 2009 Aug 24.

34.

Cerebrospinal fluid and serum NT-proBNP concentrations in children with epilepsy.

Rauchenzauner M, Haberlandt E, Rösslhuber C, Luef G, Otto M, Hammerer-Lercher A, Griesmacher A, Rostasy K.

Epilepsy Res. 2009 Oct;86(2-3):131-7. doi: 10.1016/j.eplepsyres.2009.05.013. Epub 2009 Jul 16.

PMID:
19615861
35.

A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe. The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study.

Pulkki K, Suvisaari J, Collinson P, Ravkilde J, Stavljenic-Rukavina A, Hammerer-Lercher A, Baum H, van Dieijen-Visser MP, Laitinen P.

Clin Chem Lab Med. 2009;47(2):227-34. doi: 10.1515/CCLM.2009.044.

PMID:
19099527
36.

Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure.

Hammerer-Lercher A, Halfinger B, Sarg B, Mair J, Puschendorf B, Griesmacher A, Guzman NA, Lindner HH.

Clin Chem. 2008 May;54(5):858-65. doi: 10.1373/clinchem.2007.090266. Epub 2008 Mar 13.

37.

N-terminal pro A-type natriuretic peptide but not N-terminal pro C-type natriuretic peptide concentrations are related to cardiac diseases in infants.

Hammerer-Lercher A, Puschendorf B, Sommer R, Mair J, Tulzer G, Lechner E, Hawa G, Maitzen S, Woloszczuk W.

Clin Chim Acta. 2008 May;391(1-2):118-9. doi: 10.1016/j.cca.2008.01.022. Epub 2008 Jan 30. No abstract available.

PMID:
18280250
38.

How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study.

Collinson P, Pulkki K, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Hammerer-Lercher A, Baum H, van Dieijen-Visser MP, Laitinen PH.

Clin Chem. 2008 Feb;54(2):448-9. doi: 10.1373/clinchem.2007.097501. No abstract available.

39.

Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia.

Falkensammer J, Stojakovic T, Huber K, Hammerer-Lercher A, Gruber I, Scharnagl H, Fraedrich G, Santner W, Schocke M, Greiner A.

Clin Chem Lab Med. 2007;45(4):535-40.

PMID:
17439334
40.

3-week hiking holidays at moderate altitude do not impair cardiac function in individuals with metabolic syndrome.

Mair J, Hammerer-Lercher A, Mittermayr M, Klingler A, Humpeler E, Pachinger O, Schobersberger W.

Int J Cardiol. 2008 Jan 11;123(2):186-8. Epub 2007 Feb 21.

PMID:
17316842
41.

NT-proBNP concentrations indicate cardiac disease in pediatric patients.

Geiger R, Hammerer-Lercher A, Url C, Schweigmann U, Puschendorf B, Sommer R, Stein JI, Mair J.

Int J Cardiol. 2007 Dec 15;123(1):63-5. Epub 2007 Feb 7.

PMID:
17289184
42.

B-type natriuretic peptide (BNP) is more sensitive to rapid hemodynamic changes in acute heart failure than N-terminal proBNP.

Mair J, Falkensammer G, Poelzl G, Hammerer-Lercher A, Griesmacher A, Pachinger O.

Clin Chim Acta. 2007 Apr;379(1-2):163-6. Epub 2007 Jan 3.

PMID:
17258185
43.

Natriuretic peptides correlate between newborn twins but not between twins and their mothers.

Hammerer-Lercher A, Puschendorf B, Sommer R, Mair J, Tews G, Shebl O, Hawa G, Maitzen S, Woloszczuk W.

Clin Chim Acta. 2007 Feb;377(1-2):279-80. Epub 2006 Oct 27. No abstract available.

PMID:
17069781
44.

Thermal preconditioning protects the human internal mammary artery from hypoxia/re-oxygenation-induced damage.

Hammerer-Lercher A, Haeusler C, Prelog M, Bonatti J, Hoefer D, Ruttmann E, Laufer G, Werner ER, Dirnhofer S, Puschendorf B, Mair J.

Clin Exp Pharmacol Physiol. 2006 Jul;33(7):584-90.

PMID:
16789924
45.

Direct comparison of relaxation and cGMP production in human coronary by-pass grafts in response to stimulation with natriuretic peptides and a nitric oxide donor.

Hammerer-Lercher A, Fersterer J, Holzmann S, Bonatti J, Ruttmann E, Hoefer D, Mair J, Puschendorf B.

Clin Sci (Lond). 2006 Sep;111(3):225-31.

PMID:
16709152
46.

Utility of N-terminal pro-B-type natriuretic peptide to differentiate cardiac diseases from noncardiac diseases in young pediatric patients.

Hammerer-Lercher A, Geiger R, Mair J, Url C, Tulzer G, Lechner E, Puschendorf B, Sommer R.

Clin Chem. 2006 Jul;52(7):1415-9. Epub 2006 May 11.

47.

B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are comparably useful for disease monitoring in heart failure.

Hammerer-Lercher A, Pölzl G, Falkensammer G, Ludwig W, Hügel H, Puschendorf B, Pachinger O, Mair J.

Int J Cardiol. 2006 Jan 26;106(3):415-7. No abstract available.

PMID:
16337058
48.

B-type natriuretic peptide and N-terminal pro brain natriuretic peptide are related to systolic and diastolic left ventricular function assessed by radionuclide ventriculography.

Falkensammer G, Lechleitner P, Hammerer-Lercher A, Theurl A, Puschendorf B, Mair J.

Int J Cardiol. 2005 Dec 7;105(3):340-1. No abstract available.

PMID:
16274781
49.

Possible placental exchange of neopterin as indicated by significant correlations in matched maternal neonatal blood samples at delivery.

Hammerer-Lercher A, Puschendorf B, Fuchs D, Mair J, Tews G, Shebl O, Sommer R.

Clin Chim Acta. 2006 Mar;365(1-2):350-1. Epub 2005 Sep 19. No abstract available.

PMID:
16169543
50.

B-type natriuretic peptide as a marker of allograft rejection after heart transplantation.

Hammerer-Lercher A, Mair J, Antretter H, Ruttmann E, Poelzl G, Laufer G, Puschendorf B, Hangler H.

J Heart Lung Transplant. 2005 Sep;24(9):1444.

PMID:
16143273

Supplemental Content

Loading ...
Support Center